https://www.asam.org/quality-practice/publications/asam-weekly/asam-weekly-editorial-comment
William Haning, MD, DFASAM, DFAPA
Editor-in-Chief
For “…those following the SAMHSA Treatment Episode Data Sets (TEDS) for substance use will protest that this (decrease methamphetamine abuse) is not so, and that it is not a matter of opioid use disorders replacing amphetamine use disorders in the hierarchy of drug use preferences. Prosaically, it is more likely that we just have less to say about management of amphetamine use disorders than we do of opioid or alcohol use disorders. A more detailed examination of the types of articles published under the heading of opioid use disorders indicates that the dominant theme is buprenorphine; and for alcohol use, naltrexone, medication strategies which are happily gaining traction in terms of their efficacy. Crude rates of publication are probably not a good measure of a topic’s importance.”
Comment;
It should also be noted that methamphetamine doesn’t kill as often as opiates do. Opiate overdoses cause folks to stop breathing. Methamphetamine does not have this effect–although it certainly has more complicated longer-term bad side effects!
- COVID UPDATE: What is the truth? - 2022-11-08
- Pathologist Speaks Out About COVID Jab Effects - 2022-07-04
- A Massive Spike in Disability is Most Likely Due to a Wave of Vaccine Injuries - 2022-06-30
